CASIA OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Narrowing the Gap: Improved Detector Training With Noisy Location Annotations 期刊论文
IEEE TRANSACTIONS ON IMAGE PROCESSING, 2022, 卷号: 31, 页码: 6369-6380
作者:  Wang, Shaoru;  Gao, Jin;  Li, Bing;  Hu, Weiming
Adobe PDF(1489Kb)  |  收藏  |  浏览/下载:203/25  |  提交时间:2022/11/14
Annotations  Noise measurement  Detectors  Task analysis  Training  Object detection  Degradation  Object detection  noisy label  Bayesian estimation  teacher-student learning  
MonkeyTrail: A scalable video-based method for tracking macaque movement trajectory in daily living cages 期刊论文
ZOOLOGICAL RESEARCH, 2022, 卷号: 43, 期号: 3, 页码: 343-351
作者:  Liu, Meng-Shi;  Gao, Jin-Quan;  Hu, Gu-Yue;  Hao, Guang-Fu;  Jiang, Tian-Zi;  Zhang, Chen;  Yu, Shan
Adobe PDF(8969Kb)  |  收藏  |  浏览/下载:255/13  |  提交时间:2022/07/25
Movement trajectory tracking  Video-based behavioral analyses  Background subtraction  Virtual empty background  Occlusion  
Design and Experiments of a Novel Halbach-Cylinder-Based Magnetic Skin: A Preliminary Study 期刊论文
IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT, 2022, 卷号: 71, 页码: 11
作者:  Gui, Mei-Jiang;  Zhou, Xiao-Hu;  Xie, Xiao-Liang;  Liu, Shi-Qi;  Li, Hao;  Xiang, Tian-Yu;  Wang, Jin-Li;  Hou, Zeng-Guang
收藏  |  浏览/下载:229/0  |  提交时间:2022/06/06
Soft magnetic materials  Skin  Magnetic analysis  Magnetoelasticity  Magnetic levitation  Force  Magnetic hysteresis  Analytical magnetic calculation  deformation experiments  finite element simulation  Halbach cylinder  tactile perception  
A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence 期刊论文
ACS NANO, 2020, 卷号: 14, 期号: 10, 页码: 12679-12696
作者:  Zhou, Tianjun;  Liang, Xiaolong;  Wang, Peifeng;  Hu, Yueyang;  Qi, Yafei;  Jin, Yushen;  Du, Yang;  Fang, Chihua;  Tian, Jie
收藏  |  浏览/下载:190/0  |  提交时间:2021/03/02
hepatocellular carcinoma  prussian blue  photothermal therapy  sorafenib  hypoxia  antiprogrammed death-ligand I  immunotherapy